Risk-Sharing/Performance-Based Arrangements in Central & Eastern Europe: Implementation of Managed Entry Agreements

4 February 2021

Back to all short courses

Risk-Sharing/Performance-Based Arrangements in Central & Eastern Europe: Implementation of Managed Entry Agreements

LEVEL - Intermediate
TRACK - Health Policy & Regulatory
LENGTH: 4 Hour | 1 Day Short Course

Register Now

February 4, 2021 | 4 Hours plus 30 minute break:
08:00-12:30 Eastern Standard Time (EST)
13:00-17:30 Greenwich Mean Time (GMT)
14:00-18:30 Central European Time (CET)

Basic Schedule: 

Class Time: 2 hours
Break: 30 minutes
Class Time: 2 hours

Click for time zone conversion


During the recent years, Managed Entry Agreements (MEAs) have become instrumental in ensuring the access of the innovative medicines. This course is designed for health care professionals (including public decision-makers, academia and industry) involved in pricing and reimbursement decisions who are wishing to understand the applicability and technical aspects of managed entry agreements (MEAs) in countries with severe economic constraints and explicit cost-effectiveness criterion.

The topic will be introduced with key features of pricing and reimbursement systems in Central-Eastern European countries to understand why special methods are needed to facilitate evidence-based reimbursement policies of new health technologies. Faculty will present an economic model to explain the methodology and implications of managed entry agreements in cost-effectiveness and budget impact analysis. Participants will then have the opportunity to apply what they have learned through a hands-on exercise on making pricing and reimbursement decisions. A decision algorithm will be presented to support evidence and value based policy decisions of high-cost new technologies in CEE countries. A series of password protected economic models will add more and more complexity to a pragmatic case study on a new pharmaceutical product in oncology. To close the course faculty will lead a discussion on the applicability of a pragmatic decision tool illustrating the pros and cons of different managed entry agreements and their usefulness in CEE settings. Participants who wish to gain hands-on experience must bring their laptops with Microsoft Excel for Windows installed.


Zoltan Kalo, PhD, Professor of Health Economics
1) Semmelweis University
2) Syreon Research Institute
Budapest, PE, Hungary

Rok Hren, PhD, MSc
Assistant Professor
University of Ljubljana
Ljubljana, Slovenia

Katarzyna Kolasa, PhD
Professor of Health Economics, Head of Department
Kozminski University
Warszawa, Poland 


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now